Fagron N.V.
ARSUFOTCHealthcare● Active
$27.00
+$0.47(+1.77%)
Market Cap$2.0B
P/E Ratio—
52W High$27
52W Low$20.03
Fagron N.V. (ARSUF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ARSUF · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 12, 2026EPS Actual
$0.73
Revenue
$0.56B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 12, 2026
After Market Close
ARSUF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | — | — | — | — | — | — |
| — Q1 FY2026 | Feb 12, 2026 | — | $0.73 | — | $0.56B | — | — |
| ◌ Q3 FY2025 | Jul 31, 2025 | — | — | — | $0.56B | — | — |
| — Q1 FY2025 | Feb 20, 2025 | — | $0.57 | — | $0.46B | — | — |
| — Q4 FY2024 | Oct 10, 2024 | — | $0.60 | — | $0.46B | — | — |
| — Q2 FY2024 | May 21, 2024 | — | $0.56 | — | $0.43B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.49 | — | $0.41B | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.51 | — | $0.38B | — | — |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 12, 2026
EPS Actual
$0.73
EPS Est.
—
EPS Surpr.
—
Revenue
$0.56B
Q3 FY2025
Jul 31, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
$0.56B
Q1 FY2025
Feb 20, 2025
EPS Actual
$0.57
EPS Est.
—
EPS Surpr.
—
Revenue
$0.46B
Q4 FY2024
Oct 10, 2024
EPS Actual
$0.60
EPS Est.
—
EPS Surpr.
—
Revenue
$0.46B
Q2 FY2024
May 21, 2024
EPS Actual
$0.56
EPS Est.
—
EPS Surpr.
—
Revenue
$0.43B
Q2 FY2023
Jun 30, 2023
EPS Actual
$0.49
EPS Est.
—
EPS Surpr.
—
Revenue
$0.41B
Q4 FY2022
Dec 31, 2022
EPS Actual
$0.51
EPS Est.
—
EPS Surpr.
—
Revenue
$0.38B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2025 | $0.2B | $0.2B | $0.2B | 1 |
| Q4 FY2024 | $0.2B | $0.2B | $0.2B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 12, 2026 | — | $26.00 | $26.00 | +0.00% |
| — Q1 FY2025 | Feb 20, 2025 | — | $20.03 | $20.03 | +0.00% |
| — Q4 FY2024 | Oct 10, 2024 | — | $20.85 | $20.85 | +0.00% |
| — Q2 FY2024 | May 21, 2024 | — | $18.59 | $18.59 | +0.00% |
| — Q2 FY2023 | Jun 30, 2023 | — | $16.15 | $16.15 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $13.50 | $13.50 | +0.00% |
| — Q2 FY2022 | Jun 30, 2022 | — | $17.44 | $17.44 | +0.00% |
| — Q4 FY2021 | Dec 31, 2021 | — | $15.55 | $15.55 | +0.00% |
Q1 FY2026+0.00%
Report Date
Feb 12, 2026
EPS Beat/Miss
—
Price Before
$26.00
Price After
$26.00
Q1 FY2025+0.00%
Report Date
Feb 20, 2025
EPS Beat/Miss
—
Price Before
$20.03
Price After
$20.03
Q4 FY2024+0.00%
Report Date
Oct 10, 2024
EPS Beat/Miss
—
Price Before
$20.85
Price After
$20.85
Q2 FY2024+0.00%
Report Date
May 21, 2024
EPS Beat/Miss
—
Price Before
$18.59
Price After
$18.59
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$16.15
Price After
$16.15
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$13.50
Price After
$13.50
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$17.44
Price After
$17.44
Q4 FY2021+0.00%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$15.55
Price After
$15.55
Beat Rate0 / 8 quarters
Largest Move+0.00% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ARSUF ends December
Fagron N.V. (ARSUF) most recently reported earnings on February 12, 2026 for Q1 FY2026, posting EPS of $0.73 (in line with the analyst consensus of —). The next ARSUF earnings date is expected around September 1, 2026.
Each quarter, investors track ARSUF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ARSUF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ARSUF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ARSUF earnings · 4 questionsFagron N.V.'s next earnings report is expected around September 1, 2026. ARSUF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ARSUF historically reports after market close (AMC).
ARSUF earnings datewhen is ARSUF earningsARSUF next earnings datewhen does ARSUF report earningsARSUF earnings calendar
▸ Source: FMP · Fagron N.V. SEC filings · US GAAP · Fagron N.V. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026